More Business News:
Axion BioSystems Nearly Completes $2.5M Offering - cbl
By citybizlist Staff
ATLANTA -- Axion BioSystems Inc., formerly known as Axion BioSystems LLC, has raised $2.1 million of $2.5 million in mixed securities, according to an SEC filing.
The Atlanta-based company develops multi-electrode array technology to provide access to cellular information analysis for research, clinical, and drug discovery markets.
Principals named in the Reg D filing are President and CEO Thomas O'Brien; Chief Technology Officer James Ross; Edgar Brown, chief engineer; executive officers Stephen DeWeerth, Swaminathan Rajaraman and Julian Bragg; and directors, Mark Allen and Glenn Epstein.
Reg D filing: http://tinyurl.com/3x8cvp3
Bios from Axion BioSystems' Web site:
Thomas O'Brien - President and CEO
Tom O'Brien was most recently a senior executive at Philips Medical Systems, a division of Royal Dutch Philips, after the sale of Intermagnetics. At Intermagnetics Tom held the role of Executive Vice President, Corporate Development and President, Invivo Medical Devices. Prior to that, he has held various senior executive positions in both public and private companies, in the US as well as abroad. Mr. O'Brien holds a Bachelor's Degree in Industrial Engineering from Georgia Tech and an MBA from the University of Chicago.
James Ross, Ph.D., Chief Technical Officer
James Ross was previously a product development engineer for Advanced Micro Devices and the co-founder and Chief Technology Officer of Teneo Micro Instruments, which recently launched its first product for micro-scale manipulation of MEMs components. He possesses over 7 years experience in MEMS fabrication, analog circuit design, and neural interfacing technology. During his tenure at the Microelectronics Research Center and the Laboratory for Neuroengineering, he was instrumental in producing over a dozen critically enabling technologies for the manipulation and sensing of neural tissue (many of which are patent pending). Dr. Ross received a Bachelor of Science degree in Electrical Engineering from Louisiana State University and a Doctorate in Biomedical Engineering from Georgia Tech.
Edgar Brown, Chief Engineer
Edgar Brown is currently a research engineer at the Laboratory for Neuroengineering in Atlanta, Georgia. He possesses more than 20 years experience in analog, digital, and mixed signal circuit design, as well as embedded systems and signal processing. His specialty is in ultra low-power analog integrated circuit design and neuromorphic engineering, which he has applied to the development of phased array systems and neural stimulators. Mr. Brown is a senior member for the Institute of Electronics and Electrical Engineers and holds Masters degrees in Digital Signal Processing from Universidad Simn Bolvar and Applied Mathematics from Georgia Tech.
Swaminathan Rajaraman, PhD, MEMS R&D
Swami has over 10 years of academic and industrial research experience in MEMS, biotechnology and semiconductors. He has previously worked with Analog Devices and CardioMEMS in developing MEMS fabrication technologies for optical micro-mirrors and implantable sensors respectively. His primary expertise is in developing robust and inexpensive manufacturing processes for exotic, 3D microstructures. Mr. Rajaraman received his Bachelor of Science in Electronics from Bharathidasan University in India, his Master of Science in Electrical Engineering from the University of Cincinnati, and his PhD in Electrical Engineering from the Georgia Institute of Technology.
Julian Bragg, Medical Device R&D
Julian is a fellow in the Neuromuscular program of the Emory University Department of Neurology. He has published papers in such fields as neuromorphic engineering, analog circuit design, and clinical neurophysiology. His primary research interests are the automation of clinical neurophysiological testing and the measurement and clinical applications of nerve excitability testing. He has completed a B.S. in Electrical Engineering from the George Washington University, a Ph.D. in Bioengineering from the Georgia Institute of Technology, a M.D. from Emory University School of Medicine, and a residency in Neurology at Emory.
Board of Directors
Mark Allen
Mark Allen is currently Senior Vice Provost at Georgia Tech. His main research focus is in microelectromechanical systems (MEMS), which uses microfabrication techniques to create mechanical structures in silicon and other materials that can be added to electronic devices. In addition to his academic work, he has co-founded two successful medical device companies BioValve and CardioMEMS. Mark received three bachelor degrees from the University of Pennsylvania in 1983: the B.A. in Chemistry, the B.S.E. in Chemical Engineering, and the B.S.E. in Electrical Engineering and his PhD from Massachusetts Institute of Technology.
Glenn Epstein
Glenn Epstein was most recently Chairman and CEO of Intermagnetics General Corporation (NASDAQ: IMGC). He began his career as an engineer at General Electric before moving to the U.K. to take on progressive management roles with Oxford Instruments plc. Glenn joined Intermagnetics in 1997 as President and COO, took over as CEO in 1999 and was elected Chairman in 2002. He led the company through multiple years of high growth until negotiating the sale of Intermagnetics to Royal Philips for $1.3 billion. Currently, Glenn serves on the boards of Fuel Cell Energy (NASDAQ:FCEL) and X-Ray Optical Systems. He received a BS in Mechanical Engineering from the University of Vermont.
Posted: July 29, 2010